Antihyperuricemic Therapy

• Assess for new gouty arthritis attacks or the development of tophi. If neither one develops, continue antihyperuricemic therapy as prescribed.

• Obtain the first follow-up SUA level within 6 months of starting therapy. Then monitor levels at least every 6 to 12 months, and adjust the dose to achieve a target SUA level of less than 6 mg/dL (357 ^mol/L).

• Evaluate patients taking allopurinol for development of rash, nausea, or new fever. These symptoms usually appear within the first 3 months of therapy but can occur anytime.

• Assess patients receiving probenecid for fever, nausea, or skin rash. Reevaluate therapy if a significant decrease in urine output occurs (greater than 50% in a 24-hour period).

The Prevention and Treatment of Headaches

The Prevention and Treatment of Headaches

Are Constant Headaches Making Your Life Stressful? Discover Proven Methods For Eliminating Even The Most Powerful Of Headaches, It’s Easier Than You Think… Stop Chronic Migraine Pain and Tension Headaches From Destroying Your Life… Proven steps anyone can take to overcome even the worst chronic head pain…

Get My Free Audio Book


Post a comment